Tennant FLB

Hazard statements (CLP)

H315, H317, H319, H332, H334, H335, H351, H373

Code

Statements

H315

Causes skin irritation

SECTION 2: Hazards identification

1999/45/EC EMERGENCY OVERVIEW: This product is a viscous liquid with a mild aromatic odor.

Health hazards

Exposure may cause irritation to skin. May cause irritation to eyes upon contact. Inhalation of vapors or mist at high concentrations may be harmful. May cause skin and respiratory sensitization. Flammability Hazards: This product is not a Combustible liquid with a flash point of >200°F (>93°C). Reactivity Hazards: None known

Environmental hazards

The Environmental effects of this product have not been investigated. Release of this product may have significant adverse effects in the aquatic environment. US DOT SYMBOLS

Signal word

Danger! EU LABELING AND CLASSIFICATION This product does meet the definition of a hazardous substance or preparation as defined by the European Union Council Directives 67/548/EEC, 1999/45/EC, 1272/2008/EC and subsequent Directives EU HAZARD CLASSIFICATION OF INGREDIENTS PER DIRECTIVE 1272/2008/EC Index Number EC# 247-714-0 Annex VI Index# 615-005-00-9 EC# 202-966-0 Annex VI Index# 615-005-00-9 Remainder of components are not listed in Annex VI Substances not listed either individually or in group entries must be self classified Component(s) Contributing to Classification(s) All components in Section 3 LABEL ELEMENTS GHS Hazard Classification(s) Acute Toxicity Category 4 (Inhalation) Skin Irritation Category 2 Eye Irritant Category 2A Respiratory Sensitization Category 1 Skin Sensitization Category 1 Carcinogenicity Category 2 Specific Target Organ Toxicity – Single Exposure Category 3 (Respiratory Irritation) Specific Target Organ Toxicity – Repeated Exposure Category 2 Hazard Statement(s) H332: Harmful if inhaled H315: Causes skin irritation H319: Causes serious eye irritation H334: May cause allergy or asthma symptoms or breathing difficulties if inhaled H317: May cause an allergic skin reaction H351: Suspected of causing cancer H335: May cause respiratory irritation H373: May cause damage to organs through prolonged or repeated exposure Prevention Statement(s) P201: Obtain special instructions before use P202: Do not handle until all safety precautions have been read and understood P260: Do not breathe dust/fumes/gas/mist/vapours/spray P264: Wash thoroughly after handling P271: Use only outdoors or in a well-ventilated area P272: Contaminated work clothing should not be allowed out of the workplace P280: Wear protective gloves/ protective clothing / eye and face protection P284: [In case of inadequate ventilation] wear respiratory protection Response Phrases P304+P340: IF INHALED: Remove person to fresh air and keep comfortable for breathing P312: Call a POISON CENTER/doctor if you feel unwell P302+P352: IF ON SKIN: Wash with plenty of water P321: Specific treatment (See Section 4 on this SDS) P333+P313: If skin irritation or rash occurs: Get medical attention P362+P364: Take off contaminated clothing and wash it before reuse P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing P337+P313: If eye irritation persists: Get medical advice/attention P342+P311: If experiencing respiratory symptoms: Call a POISON CENTER/doctor P308+P313: IF exposed or concerned: Get medical advice/attention Storage Phrases P405: Store locked up P403+P233: Store in a well-ventilated place. Keep container tightly closed Disposal Phrases P501: Dispose of contents/container in accordance with local/regional/national/international regulations HEALTH HAZARDS OR RISKS FROM EXPOSURE SYMPTOMS OF OVEREXPOSURE BY ROUTE OF EXPOSURE: The most significant routes of overexposure for this product are by contact with skin or eyes, inhalation and ingestion. The symptoms of overexposure are described below ACUTE INHALATION: TDI vapors or mist at concentrations above the TLV can irritate (burning sensation) the mucous membranes in the respiratory tract (nose, throat, lungs) causing runny nose, sore throat, coughing, chest discomfort, shortness of breath and reduced lung function (breathing obstruction). High vapor concentrations may cause central nervous system (CNS) depression as evidenced by giddiness, headache, dizziness, and nausea CONTACT WITH SKIN: Isocyanates react with skin protein and moisture and can cause irritation. Prolonged contact can cause reddening, swelling, rash, scaling, blistering, and, in some cases, skin sensitization EYE CONTACT: Liquid, aerosols or vapors are severely irritating and can cause pain, tearing, reddening and swelling INGESTION: Can result in irritating and corrosive action in the mouth, stomach tissue and digestive tract. Symptoms can include sore throat, abdominal pain, nausea, vomiting and diarrhea CHRONIC: Repeated exposure above current occupational limits may cause an allergic sensitization of the respiratory tract. This is characterized by an asthma-like response upon re-exposure to the chemical. The symptoms may include coughing, wheezing, shortness of breath and chest tightness, and may be fatal Central nervous system (CNS) impairment leading to unconsciousness TARGET ORGANS: Acute: Skin, Respiratory System and Eyes Chronic: Skin, Respiratory System

2.1 Classification of the substance or mixture

This product does meet the definition of a hazardous substance or preparation as defined by the European Union Council Directives 67/548/EEC, 1999/45/EC, 1272/2008/EC and subsequent Directives. EU HAZARD CLASSIFICATION OF INGREDIENTS PER DIRECTIVE 1272/2008/EC: Index Number: EC# 247-714-0 Annex VI Index# 615-005-00-9 EC# 202-966-0 Annex VI Index# 615-005-00-9 Remainder of components are not listed in Annex VI Substances not listed either individually or in group entries must be self classified. Component(s) Contributing to Classification(s) All components in Section 3